tiprankstipranks
Advertisement
Advertisement

VNRX Stock Latest News

Is VNRX a Buy, Before Earnings?
Pre-EarningsIs VNRX a Buy, Before Earnings?
11h ago
VNRX
Morning News Wrap-Up 3/25/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 3/25/26: Today’s Biggest Stock Market Stories!
4d ago
HD
AMD
Why is VolitionRX Stock (VNRX) Up 24% Today?
PremiumMarket News
Why is VolitionRX Stock (VNRX) Up 24% Today?
4d ago
VNRX
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems
PremiumThe Fly
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems
23d ago
VNRX
VolitionRx Issues Shares to Satisfy Convertible Note Obligations
PremiumCompany Announcements
VolitionRx Issues Shares to Satisfy Convertible Note Obligations
1M ago
8K
VNRX
VolitionRx receives non-compliance notice from NYSE American
PremiumThe FlyVolitionRx receives non-compliance notice from NYSE American
2M ago
VNRX
VolitionRx files to sell 17.97M shares of common stock for holders
Premium
The Fly
VolitionRx files to sell 17.97M shares of common stock for holders
2M ago
VNRX
VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
Premium
The Fly
VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
2M ago
VNRX
VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia
PremiumThe Fly
VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia
2M ago
VNRX
VolitionRx announces clinical data for Nu.Q Vet cancer test in cats
PremiumThe Fly
VolitionRx announces clinical data for Nu.Q Vet cancer test in cats
3M ago
VNRX
VolitionRX Announces CEO Departure Amid Cost Realignment
PremiumCompany Announcements
VolitionRX Announces CEO Departure Amid Cost Realignment
4M ago
8K
VNRX
VolitionRx announces new paper on Capture-Seq, achieves 180-fold enrichment
PremiumThe Fly
VolitionRx announces new paper on Capture-Seq, achieves 180-fold enrichment
4M ago
VNRX
VolitionRX Gains Momentum with Strategic Advancements in Sepsis and Cancer Diagnostics
PremiumRatingsVolitionRX Gains Momentum with Strategic Advancements in Sepsis and Cancer Diagnostics
4M ago
VNRX
VolitionRx downgraded to Hold from Buy at Maxim
Premium
The Fly
VolitionRx downgraded to Hold from Buy at Maxim
4M ago
VNRX
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright
Premium
The Fly
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright
4M ago
VNRX
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships
PremiumCompany Announcements
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships
4M ago
VNRX
VolitionRx Limited Reports Q3 2025 Financial Growth
PremiumCompany Announcements
VolitionRx Limited Reports Q3 2025 Financial Growth
4M ago
VNRX
VolitionRx reports Q3 revenue $600,000, consensus $715,590
PremiumThe Fly
VolitionRx reports Q3 revenue $600,000, consensus $715,590
5M ago
VNRX
VNRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VNRX Earnings this Week: How Will it Perform?
5M ago
VNRX
VolitionRX Amends Underwriting Agreement for Stock Offering
PremiumCompany AnnouncementsVolitionRX Amends Underwriting Agreement for Stock Offering
5M ago
8K
VNRX
VolitionRx announces pricing of $6M offering of common stock, warrants
Premium
The Fly
VolitionRx announces pricing of $6M offering of common stock, warrants
6M ago
VNRX
VolitionRx announces offering of common stock and warrants, no amount given
Premium
The Fly
VolitionRx announces offering of common stock and warrants, no amount given
6M ago
VNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >